-
Study aim
-
Comparison of Mean Levels of Testosterone, Cholesterol, Triglyceride, Oocyte Quality, Embryo Quality, BMI, LH, FSH in Two Groups Treated with Inositol and Sitagliptin Addition to Inositol
-
Design
-
The Clinical Trial, One Control Group with a Parallel Group,double Blind, Randomized, Phase 3 on 70 Patients who will be Randomized with Block Method
-
Settings and conduct
-
Body Mass Index and Levels of Fating Blood Sugar, Luteinizing Hormone & Follicle-Stimulation Hormone, Triglyceride, Cholesterol and Testosterone are Evaluated Before Starting in Both Groups. Group A will Receive their Routine Medications Plus Sitagliptin Tablet and Inofolic Powder, and Group B will Receive their Routine Medications Plus Inofolic Powder, 8 Weeks Before the Start of In Vitro Fertilization Cycle in the Infertility Center of Shahid Beheshti Hospital in Kashan, and then Embryo Transfer will be Done with Appropriate Quality. The Quality of Embryo and Oocyte and Laboratory Criteria and Body Mass Index will be Investigated in Two Groups
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria People with Polycystic Ovarian Syndrome, Age Between 18 and 40 Years Old, Known Case of Polycystic Ovarian Syndrome, and Based on their Infertility Records, are Candidates for Entering the Cycle of Infertility Treatment and ICSI; Exclusion Criteria People with Uterine Abnormalities
-
Intervention groups
-
Group Treated with Inositol
Group Treated with Inositol and Sitagliptin
-
Main outcome variables
-
Embryo Quality, Oocyte Quality